Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Potential transmission of viral hepatitis through use of stored blood vessels as conduits in organ transplantation--Pennsylvania, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 18;60(6):172-4.

2.

Potential transmission of viral hepatitis through use of stored blood vessels as conduits in Organ Transplantation-Pennsylvania, 2009.

Centers for Disease Control and Prevention (CDC).

Am J Transplant. 2011 Apr;11(4):863-5. doi: 10.1111/j.1600-6143.2011.03522.x. No abstract available.

3.

Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.

Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, Burke GW, Nery JR, Esquenazi V, et al.

Ann Intern Med. 1992 Sep 15;117(6):470-5.

PMID:
1323944
4.

Outcome of hepatitis B and C virus infection on graft function after renal transplantation.

Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.

Transplant Proc. 2005 Sep;37(7):3045-7.

PMID:
16213299
5.
6.

Should hepatitits-C virus antibody-positive donors be excluded from kidney donation?

Pouteil-Noble C, Tardy JC, Chossegros P, Trepo C, Aymard M, Touraine JL.

Transpl Int. 1992;5 Suppl 1:S44-6.

PMID:
14621728
7.

Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.

Ahn J, Cohen SM.

Liver Transpl. 2008 Nov;14(11):1603-8. doi: 10.1002/lt.21534.

8.

The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.

Yao F, Seed C, Farrugia A, Morgan D, Cordner S, Wood D, Zheng MH.

Am J Transplant. 2007 Dec;7(12):2723-6.

9.

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.

Velati C, RomanĂ² L, Fomiatti L, Baruffi L, Zanetti AR; SIMTI Research Group.

Transfusion. 2008 Oct;48(10):2205-13. doi: 10.1111/j.1537-2995.2008.01813.x. Epub 2008 Jul 8.

PMID:
18631163
10.

Donor screening for hepatitis B virus infection in a cell and tissue bank.

Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.

Transpl Infect Dis. 2008 Dec;10(6):391-5. doi: 10.1111/j.1399-3062.2008.00331.x. Epub 2008 Jul 28.

PMID:
18665905
11.

Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.

Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH.

Transpl Immunol. 2004 Dec;13(4):305-11.

PMID:
15589744
12.

Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.

Ko WJ, Chou NK, Hsu RB, Chen YS, Wang SS, Chu SH, Lai MY.

J Heart Lung Transplant. 2001 Aug;20(8):865-75.

PMID:
11502409
13.

Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.

Fabrizio F, Bunnapradist S, Martin P.

J Nephrol. 2002 Nov-Dec;15(6):605-13. Review.

PMID:
12495272
14.

Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.

Aswad S, Khan NS, Comanor L, Chinchilla C, Corado L, Mone T, Mendez R, Mendez R.

J Viral Hepat. 2005 Nov;12(6):627-34.

PMID:
16255764
15.

The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.

Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, et al.

Transplantation. 1995 Jan 27;59(2):230-4.

PMID:
7839446
16.

Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.

De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M; Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups.

Transplant Proc. 2005 Mar;37(2):1238-9.

PMID:
15848681
17.

Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.

Challine D, Chevaliez S, Pawlotsky JM.

Gastroenterology. 2008 Oct;135(4):1185-91. doi: 10.1053/j.gastro.2008.07.011. Epub 2008 Jul 17.

PMID:
18694749
18.

Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.

Madayag RM, Johnson LB, Bartlett ST, Schweitzer EJ, Constantine NT, McCarter RJ Jr, Kuo PC, Keay S, Oldach DW.

Transplantation. 1997 Dec 27;64(12):1781-6.

PMID:
9422420
19.

Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.

Seem DL, Lee I, Umscheid CA, Kuehnert MJ.

Am J Transplant. 2013 Aug;13(8):1953-62. doi: 10.1111/ajt.12386.

20.

Utilization of a liver allograft from a hepatitis B surface antigen positive donor.

Ho JK, Harrigan PR, Sherlock CH, Steinbrecher UP, Erb SR, Mo T, Chung SW, Buczkowski AK, Intaraprasong P, Scudamore CH, Yoshida EM.

Transplantation. 2006 Jan 15;81(1):129-31.

PMID:
16421489

Supplemental Content

Support Center